GlucoTrack (GCTK) AGM 2026 summary

Opening remarks and agenda

• Meeting commenced at 12:00 P.M. Eastern Time, chaired by the CEO, with all directors and outside counsel present.

• Agenda was adopted, and official business was outlined for the session.

Board and executive committee updates

• Six directors were nominated and elected to serve until the 2027 annual meeting.

Shareholder proposals

• Advisory approval of 2025 executive compensation for named executive officers was presented.

• Ratification of CBIZ CPAs, P.C. as independent auditor for fiscal year ending December 31, 2026, was proposed.

• Approval of amendments to the certificate of incorporation for potential reverse stock splits at a ratio up to 1-for-30 was proposed.

• Approval of warrant inducement, including repricing and issuance of inducement warrants, was proposed to comply with Nasdaq Rule 5635.